002287.SZ SHZ
Tibet Cheezheng Tibetan Medicine Co., Ltd.
1W: -1.7%
1M: -3.8%
3M: -1.6%
YTD: -22.1%
1Y: -32.9%
3Y: -11.1%
5Y: -20.1%
¥19.38 ($2.89)
+0.26 (+1.36%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Cash Flow Trends
Operating Cash Flow
$457M
-34.1% ▼
5Y CAGR: +2.4%
Capital Expenditures
$255M
-8.8% ▼
5Y CAGR: +37.3%
Free Cash Flow
$201M
-56.1% ▼
5Y CAGR: -10.7%
Dividends Paid
$282M
-28.4% ▼
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$199M
-305.4% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $406M | $711M | $470M | $579M | $581M |
| Depreciation & Amort. | $44M | $66M | $83M | $93M | $139M |
| Stock-Based Comp. | $10M | $5M | $1M | $0 | $0 |
| Change in Working Capital | -$303M | $521M | -$375M | -$968K | -$233M |
| Other Non-Cash Items | $99M | -$306M | $112M | $22M | -$31M |
| Operating Cash Flow | $239M | $1.0B | $286M | $693M | $457M |
| — Investing Activities — | |||||
| Capital Expenditures | -$339M | -$126M | -$272M | -$235M | -$255M |
| Acquisitions (Net) | $339M | -$61M | -$4M | $0 | $0 |
| Investment Purchases | -$830M | -$3.5B | -$1.4B | -$1.5B | -$2.5B |
| Investment Sales | $576M | $1.5B | $1.4B | $1.4B | $2.2B |
| Other Investing | -$339M | $2K | $4M | $37K | $0 |
| Investing Cash Flow | -$592M | -$2.2B | -$334M | -$311M | -$518M |
| — Financing Activities — | |||||
| Net Debt Issuance | $240M | $158M | $169M | -$202M | $151M |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | -$186M | -$180M | -$313M | -$220M | -$282M |
| Other Financing | $792M | -$5M | -$7M | -$10M | -$7M |
| Financing Cash Flow | $839M | -$43M | -$183M | -$432M | -$138M |
| Net Change in Cash | $483M | -$1.2B | -$229M | -$49M | -$199M |
| Cash End of Period | $1.8B | $667M | $438M | $389M | $190M |
| Free Cash Flow | -$100M | $909M | $13M | $459M | $201M |